CD276 and malignant colon neoplasm: Interestingly, nuclear localisation of B7-H3 strongly predicted poor outcome in colon cancer, suggesting that nuclear B7-H3 might be considered a new biomarker that could facilitate colon cancer treatment decisions, pending validation of the results in other CRC cohorts.